Brief: Cidara Therapeutics Announces Receipt Of Nasdaq Delinquency Notice
22/04/2024 23:00
April 22 (Reuters) - Cidara Therapeutics Inc CDTX.O :
* CIDARA THERAPEUTICS ANNOUNCES RECEIPT OF NASDAQ
DELINQUENCY
NOTICE
Source text for Eikon: ID:nGNX5WY3zH
Further company coverage: CDTX.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Cidara Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Merck Seeks Up To $8 Billion In Us Bond Sale Tied To Cidara Deal - Bloomberg News
Merck rises after Wells Fargo upgrades stock to 'overweight'
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade